MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Dopa-responsive dystonia(DRD)"

  • MDS Virtual Congress 2021

    MDSGene systematic review on dopa-responsive dystonia caused by mutations in GCH1, TH, SPR, PTS, or QDPR

    A. Weissbach, R. Herzog, M. Pauly, L. Hahn, I. König, S. Camargos, B. Jeon, M. Kurian, T. Opladen, N. Brüggemann, C. Klein, K. Lohmann (Lübeck, Germany)

    Objective: To systematically review information regarding genotype, phenotype, and biochemistry in dopa-responsive dystonia (DRD). Background: To date, five causative genes (GCH1, TH, SPR, PTS, and…
  • MDS Virtual Congress 2021

    A case of dystonia-parkinsonism associated with a heterozygous PRKRA (DYT16) gene mutation

    J. Wu, M. Christie, M. Schiess (Houston, USA)

    Objective: We describe the clinical presentation, diagnosis, and treatment of a case of dystonia-parkinsonism associated with a heterozygous mutation in the initiator methionine of the…
  • MDS Virtual Congress 2020

    The clinical features, treatments and genetic characteristics in Chinese children with dopa-responsive dystonia

    L. Dai, C. Ding, F. Fang (Beijing, China)

    Objective: To investigate the clinical manifestations, treatment and genetic characteristics of dopa-responsive dystonia (DRD). Background: Dopa-responsive dystonia (DRD) is resulted by variants of GCH1, TH and SPR. There…
  • MDS Virtual Congress 2020

    Recent Clinical variation of Segawa Disease in Japan

    K. Hoshino, K. Kimura, Y. Nagao, M. Fukumizu, H. Fukutda, M. Nozaki, M. Hayashi, I. Kawahata (Tokyo, Japan)

    Objective: To analyze clinical phenotype of recent variation of Segawa disease(GCHⅠ deficiency, DYT5a)in Japan. Background: Segawa Disease(SD)is  major  dystonia in children found by Prof.Masaya Segawa…
  • MDS Virtual Congress 2020

    Genetic testing in pediatric dystonia and influence of clinical factors on diagnostic yield

    T. Larsh, H. Fernandez, M. Aldosari (Cleveland, OH, USA)

    Objective: To identify the yield of genetic testing in suspected genetically determined pediatric dystonia. Identify differences in clinical factors among patients with confirmatory and non-confirmatory…
  • MDS Virtual Congress 2020

    A New Complex dystonic presentation of a rare gene – CACNA1B and its response to Levodopa

    S. Medarametla, B. Nataraju, S. Kodapala, S. Raju (Bangalore, India)

    Objective: We report a case of complex dystonia with the rare gene- CACNA1B. Background: CACNA1B gene has previously been reported as the cause of myoclonus-…
  • MDS Virtual Congress 2020

    Late-Onset Dopa-Responsive Dystonia: A Case Report

    O. Oztop Cakmak, S. Ertan, S. Tekgul, N. Basak (Istanbul, Turkey)

    Objective: To present a rare cause of treatable dystonia with onset during adulthood. Background: L-Dopa-responsive dystonia is an inherited disorder characterized by early-onset dystonia affecting…
  • 2019 International Congress

    Different clinical entities of Segawa syndrome within a family

    J. Sarangerel (Ulaanbaatar, Mongolia)

    Objective: We report two cases of mother and daughter, both having different expressions of dystonic movements. Background: One of rare dystonic disorders is Segawa syndrome…
  • 2019 International Congress

    Spectrum of parkinsonian phenotypes associated with GCH1 mutation.

    D. Al-Shorafat, A. Shetty, D. Munoz, A. Fasano, A. Lang (Toronto, ON, Canada)

    Objective: To describe the heterogeneity of parkinsonism in patients with GCH1 mutations. Background: Dopa-responsive dystonia (DRD) is an inherited disorder that responds dramatically to levodopa…
  • 2019 International Congress

    PRKN Positive Parkinson’s Disease Masked as Dopa-Responsive Dystonia

    S. Chiu, A. Elkouzi, L. Almeida (Gainesville, FL, USA)

    Objective: To report a Parkinson’s disease (PD) patient with PRKN mutation initially diagnosed with dopa-responsive dystonia (DRD), unmasked after developing signs of parkinsonian disease progression.…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • An atypical and interesting feature of Parkinson´s disease
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley